Institute of Pathology, Friedrich Alexander University Erlangen-Nürnberg, University Hospital, Erlangen.
Department of Pathology, Charles University, Faculty of Medicine in Plzen.
Am J Surg Pathol. 2021 Nov 1;45(11):1541-1549. doi: 10.1097/PAS.0000000000001719.
Clear cell (hemangioblastoma-like) stromal tumor of the lung (CCST-L) is a recently described distinctive rare pulmonary neoplasm of unknown histogenesis and molecular pathogenesis. Only 7 cases have been reported in 2 recent studies, although additional cases might have been reported under the heading of extraneural pulmonary hemangioblastoma. We herein describe 4 CCST-L cases, 3 of them harboring a YAP1-TFE3 fusion. The fusion-positive tumors occurred in 3 women, aged 29, 56, and 69 years. All presented with solitary lung nodules measuring 2.3 to 9.5 cm. Histologically, all tumors showed similar features being composed of relatively uniform medium-sized epithelioid to ovoid cells with clear cytoplasm and small round monomorphic nuclei. Scattered larger cells with enlarged hyperchromatic nuclei and marked pleomorphism were noted in 2 cases. The tumors were associated with a hypervascularized stroma with variable but essentially subtle resemblance to capillary hemangioblastoma and perivascular epithelioid cell tumor (PEComa). Immunohistochemistry was negative for all lineage-specific markers. Targeted RNA sequencing showed a YAP1-TFE3 fusion in 3 of 4 cases. All 3 tumors showed homogeneous nuclear TFE3 immunoreactivity. Two patients were disease free at 36 and 12 months. The third patient had biopsy-proven synchronous renal and hepatic metastases, but extended follow-up is not available (recent case). The fourth case lacking the fusion affected a 66-year-old woman and showed subtle histologic differences from the fusion-positive cases, but had comparable TFE3 immunoreactivity. CCST-L represents a distinctive entity unrelated to hemangioblastoma and likely driven by recurrent YAP1-TFE3 fusions in most cases. The relationship of our cases to the recently reported "hemangioblastoma-like" CCST-L remains to be determined. Analysis of larger series is paramount to delineate the morphologic spectrum and biological behavior of this poorly characterized entity.
肺透明细胞(血管外皮瘤样)间质瘤(CCST-L)是一种新近描述的独特的肺部罕见肿瘤,其组织发生和分子发病机制尚不清楚。仅有 2 项近期研究报道了 7 例,尽管在“肺神经外血管外皮瘤”的标题下可能有更多病例报道。我们在此描述了 4 例 CCST-L 病例,其中 3 例存在 YAP1-TFE3 融合。融合阳性肿瘤发生于 3 名女性,年龄分别为 29 岁、56 岁和 69 岁。所有患者均表现为单发肺部结节,大小为 2.3 至 9.5cm。组织学上,所有肿瘤均具有相似的特征,由相对均匀的中等大小上皮样至卵圆形细胞组成,胞质透明,核小而形态一致。2 例可见散在较大细胞,核增大、深染,异型性明显。肿瘤与富含血管的基质相关,其血管结构与毛细血管型血管外皮细胞瘤(PEComa)具有可变但基本微妙的相似性。免疫组织化学染色均为所有谱系特异性标志物阴性。靶向 RNA 测序显示 4 例中有 3 例存在 YAP1-TFE3 融合。所有 3 例肿瘤均表现为均匀核 TFE3 免疫反应性。2 例患者分别在 36 个月和 12 个月时无病生存。第 3 例患者有活检证实的肾和肝同步转移,但无进一步随访(最近的病例)。第 4 例无融合的病例影响了一名 66 岁女性,与融合阳性病例相比具有细微的组织学差异,但具有可比的 TFE3 免疫反应性。CCST-L 是一种独特的实体,与血管外皮细胞瘤无关,在大多数情况下可能由反复发生的 YAP1-TFE3 融合驱动。我们的病例与最近报道的“血管外皮瘤样”CCST-L 的关系尚待确定。分析更大的系列对于阐明这种特征不明确实体的形态学谱和生物学行为至关重要。